A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
about
Ocular Manifestations and Therapeutic Options in Patients with Familial Amyloid Polyneuropathy: A Systematic ReviewSafety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis.Long-term data from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR).Recent progress in the understanding and treatment of transthyretin amyloidosis.Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis.Recent advances in transthyretin amyloidosis therapyOculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient.Prevalence of and Factors Associated with Dural Thickness in Patients with Mild Cognitive Impairment and Alzheimer's DiseaseA novel amyloidogenic transthyretin variant, Gly53Ala, associated with intermittent headaches and ataxia.Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 casesTransthyretin: the servant of many masters.Early onset vitreous amyloidosis in familial amyloidotic polyneuropathy with a transthyretin Glu54Gly mutation is associated with elevated vitreous VEGF.Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation.CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.CSP-1103 (CHF5074) stabilizes human transthyretin in healthy human subjects.Atrial Fibrillation and Central Nervous Complications in Liver Transplanted Hereditary Transthyretin Amyloidosis Patients.Suppression of choroid plexus transthyretin levels by antisense oligonucleotide treatment.Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosis.Vitreous amyloidosis in two large mainland Chinese kindreds resulting from transthyretin variant Lys35Thr and Leu55Arg.CHF5074 (CSP-1103) stabilizes human transthyretin in mice humanized at the transthyretin and retinol-binding protein loci.Familial and Senile Amyloidosis Caused by TransthyretinAbstractsReport of five rare or previously unknown amyloidogenic transthyretin mutations disclosed in SwedenUnderstanding and Ameliorating the TTR AmyloidosesMulti-elemental analysis of serum and amyloid fibrils in familial amyloid polyneuropathy patients
P2860
Q26777591-5F1DE9A8-D9C8-4BAA-A921-4AC7335088D5Q33423160-A7247C44-8ECA-4011-A63C-57B4887F504EQ33991826-460A9A20-5DD8-4652-9927-085A506407F2Q34416193-17EA41B4-5278-40DE-AED7-A71AD1701B36Q34581917-0C351B07-5385-4F49-AE03-F98B80EB283FQ34664696-A8414B98-587A-44B4-A12A-900E7FBCDC3FQ34907093-F4E0307D-AFE5-4617-969F-A96B6B22A184Q35950712-A7E21F67-0D34-4991-B3FB-4103142A8D84Q36142867-562C3965-6B70-41CC-B3FE-99EF8AE7F618Q36357240-B6E7BB9C-BD31-4453-ABB9-5684D027F3CDQ36763960-90DDD2D9-9012-40F4-8EF4-91E98D21BFDFQ36830566-9CE9B82E-1C3A-4AAA-AD52-1EE6D013B147Q44155172-772F4A9C-AFAE-4390-A0EF-4CDC4AE8CEC8Q46483795-B86C3375-390A-4D53-AD72-EFCE04F77363Q47561760-86B3C798-797B-4192-BCFA-FF694573A6CAQ47924309-08BCF726-9275-48BF-9492-698EF7403BDFQ48024461-9F3F93C0-3E11-4A8B-9C20-C300296D0D1EQ48201751-6EC08D1A-D821-425F-A027-18B494303321Q48388591-1F6DFCAD-AF74-4B8C-9E69-30A635F4C74BQ50527948-A82F3DBF-97E0-4236-8763-D1B44EE3D131Q51654182-F5EE5AAD-B888-4218-8C53-562D0EA2C98CQ56031907-B1D27C31-EC9F-405A-8B75-E4A7EF7C41D2Q57259399-CF05B9D2-13EE-4540-A04E-4BEFDD91A266Q57259431-2C0D3843-B0CB-44A4-994F-7CFAC9598FA6Q57445076-B6064946-CA29-42BC-B493-786D7A651AF8Q58255179-9CA6C5F8-DF67-4ED7-ABDF-08FED57C892A
P2860
A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
A different amyloid formation ...... s after liver transplantation.
@en
A different amyloid formation ...... s after liver transplantation.
@nl
type
label
A different amyloid formation ...... s after liver transplantation.
@en
A different amyloid formation ...... s after liver transplantation.
@nl
prefLabel
A different amyloid formation ...... s after liver transplantation.
@en
A different amyloid formation ...... s after liver transplantation.
@nl
P2093
P1433
P1476
A different amyloid formation ...... s after liver transplantation.
@en
P2093
Hidenobu Tanihara
Hiroaki Okabe
Hisayasu Terazaki
Katsuki Haraoka
Makoto Uchino
Masaaki Nakamura
Mitsuharu Ueda
Taro Yamashita
Yukihiro Inomata
P304
P356
10.1097/01.TP.0000111516.60013.E6
P577
2004-02-01T00:00:00Z